TickerFactsScreenerDevelopers

Neurogene Inc. (NGNE) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2016: -$30.23M2017: -$44.72M2018: -$31.58M2019: -$15.39M2020: -$24.57M2021: -$47.56M2022: -$52.82M2023: -$51.42M2024: -$70.60M2025: -$77.17M-$77.17M
2016Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$77.17M-9.3%
2024-$70.60M-37.3%
2023-$51.42M+2.7%
2022-$52.82M-11.1%
2021-$47.56M-93.5%
2020-$24.57M-59.6%
2019-$15.39M+51.2%
2018-$31.58M+29.4%
2017-$44.72M-47.9%
2016-$30.23M—